Sign in

CIK 0000318154 · Large accelerated filer

Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. ARS Other Annual Report to Security Holders
  4. 4 Shares withheld for taxes EVP, Operations gave up 3,393 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP & Chief Technology Officer gave up 3,635 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, Human Resources gave up 930 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, Business Development gave up 489 shares (to pay taxes)
  8. 4 Shares withheld for taxes SVP & CCO gave up 524 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP & CFO gave up 3,305 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP & Gen. Counsel & Secy. gave up 3,150 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP, Global Commercial Ops gave up 4,039 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chairman, CEO and President gave up 12,853 shares (to pay taxes)
  13. 4 Shares withheld for taxes VP, Finance & CAO gave up 174 shares (to pay taxes)
  14. 4 Grant or award EVP, Operations acquired 6,792 shares (grant or award)
  15. 4 Grant or award EVP & Chief Technology Officer acquired 7,277 shares (grant or award)
  16. 4 Grant or award SVP, Human Resources acquired 2,005 shares (grant or award)
  17. 4 Grant or award SVP, Business Development acquired 1,403 shares (grant or award)
  18. 4 Grant or award SVP & CCO acquired 1,503 shares (grant or award)
  19. 4 Grant or award EVP & CFO acquired 7,277 shares (grant or award)
  20. 4 Grant or award EVP & Gen. Counsel & Secy. acquired 6,306 shares (grant or award)

Page 11 of 161 · 3,201 filings